Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Limbic encephalitis: a probably under-recognized syndrome].

F Graus1, A Saiz

  • 1Servicio de Neurología, Hospital Clínic, Barcelona. fgraus@clinic.ub.es

Neurologia (Barcelona, Spain)
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Detection of Ultrahigh Energy Emission from Gamma-Ray Binary LS I +61° 303.

Physical review letters·2026
Same author

Evidence of Cosmic-Ray Acceleration up to Sub-PeV Energies in the Supernova Remnant IC 443.

Physical review letters·2026
Same author

Precise Measurement of the Cosmic Ray Helium Spectrum above 0.1 PeV.

Physical review letters·2026
Same author

Ketogenic diet causes bone loss in growing and adult mice and reduces the skeletal response to exercise.

Bone·2026
Same author

All-Sky Search for Individual Primordial Black Hole Bursts with LHAASO.

Physical review letters·2025
Same author

Efficacy of cognitive rehabilitation in cognition and brain networks: A randomised clinical trial in patients with multiple sclerosis.

NeuroImage. Clinical·2025
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

Limbic encephalitis, a brain inflammation, presents with memory loss and seizures. Early diagnosis and treatment, including immunosuppressants, are crucial for managing this condition, especially when linked to voltage-gated potassium channel antibodies.

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Context:

  • Limbic encephalitis, identified in 1968, was historically linked to cancers.
  • Recent findings reveal idiopathic cases with anti-voltage-gated potassium channel (VGKC) antibodies, suggesting it's under-recognized.
  • The syndrome develops rapidly, causing short-term memory loss, seizures, confusion, and psychiatric symptoms.

Purpose:

  • To review the clinicopathological entity of limbic encephalitis.
  • To discuss the extended etiological spectrum, including idiopathic forms and paraneoplastic origins.
  • To outline diagnostic criteria and treatment strategies for limbic encephalitis.

Summary:

  • Diagnostic workup includes EEG, brain MRI, CSF analysis, and antibody testing (onconeural and anti-VGKC).

Related Experiment Videos

  • Treatment involves methylprednisolone cycles, with excellent response in idiopathic cases and variable response in others.
  • Identifying onconeural antibodies confirms paraneoplastic origin, guiding tumor search and treatment prediction.

    • Impact:

    • Highlights the importance of recognizing idiopathic limbic encephalitis and its association with anti-VGKC antibodies.
    • Emphasizes prompt initiation of treatment, even before antibody results are available.
    • Provides a framework for diagnosing and managing limbic encephalitis, improving patient outcomes.